#Purdue Pharma

#Purdue Pharma

The Supreme Court heard arguments over a bankruptcy deal for Purdue Pharma that would shield the Sackler family from additional opioid-related lawsuits.

The court's decision could have significant consequences for other cases that use the bankruptcy system to settle mass injury claims. [ more ]

The Supreme Court justices are divided on the bankruptcy settlement for Purdue Pharma that would shield the Sackler family from civil lawsuits related to the opioid epidemic.

The case raises questions about the practical effect of unraveling the agreement and the broader concerns over the Sacklers' liability in the opioid crisis. [ more ]

The Supreme Court is considering a challenge to a deal that would compensate victims of the opioid epidemic while protecting the Sackler family from lawsuits.

The justices are grappling with the dilemma of prioritizing money or principle in deciding the fate of the multi-billion dollar Purdue Pharma bankruptcy deal. [ more ]

The Supreme Court is hearing arguments on whether a settlement involving Purdue Pharma and the Sackler family is a violation of federal law, with potential implications for other organizations using bankruptcy court to resolve mass injury claims.

The case revolves around whether a legal maneuver in the settlement agreement can grant the Sackler family full immunity from civil lawsuits related to the opioid crisis. [ more ]